After decades of unfulfilled potential, the commercial reality of gene therapies are beginning to take shape. However, the leading drug developer organizations in this field are telling us that they have little visibility of which contract service providers have the technical experience, capacity and flexibility to meet their demands.
Senior decision makers at these leading companies will come together this October at Gene Therapy for Rare Disorders Europe, actively seeking to collaborate with organisations that can help them accelerate their gene therapy development.
Below are some figures demonstrating the calibre of the audience we brought together at the recent US-based version of this event:
If you have capabilities that would benefit our audience in the gene therapy space, Gene Therapy for Rare Disorders Europe will provide a unique platform to showcase your solutions, generate new business leads and source opportunities for partnerships.
Act now to stay ahead of the curve and seize the wealth of opportunity on offer.
Email us at firstname.lastname@example.org for more information about the partnership opportunities available which will deliver on your commercial objectives this year.